-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
Clinical outcomes in non-valvular atrial fibrillation with low CHA 2 DS 2 -VASc score after coronary stent implantation with and without hyperhomocysteinemia
Xiu Feng Xie, Tian Chang Li
Research Paper: Clinical Investigation
-
BG-12 (dimethyl fumarate) in the treatment of multiple sclerosis
Oscar Fernandez
Review: Clinical Trail Outcomes: Clinical Investigation
-
BG-12 (dimethyl fumarate) in the treatment of multiple sclerosis
Oscar Fernandez
Review: Clinical Trail Outcomes: Clinical Investigation
-
BG-12 (dimethyl fumarate) in the treatment of multiple sclerosis
Oscar Fernandez
Review: Clinical Trail Outcomes: Clinical Investigation
-
BG-12 (dimethyl fumarate) in the treatment of multiple sclerosis
Oscar Fernandez
Review: Clinical Trail Outcomes: Clinical Investigation
-
BG-12 (dimethyl fumarate) in the treatment of multiple sclerosis
Oscar Fernandez
Review: Clinical Trail Outcomes: Clinical Investigation
-
BG-12 (dimethyl fumarate) in the treatment of multiple sclerosis
Oscar Fernandez
Review: Clinical Trail Outcomes: Clinical Investigation
-
BG-12 (dimethyl fumarate) in the treatment of multiple sclerosis
Oscar Fernandez
Review: Clinical Trail Outcomes: Clinical Investigation
-
BG-12 (dimethyl fumarate) in the treatment of multiple sclerosis
Oscar Fernandez
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ibudilast for the treatment of drug addiction and other neurological conditions
Kirk W Johnson, Kazuko Matsuda & Yuichi Iwaki
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ibudilast for the treatment of drug addiction and other neurological conditions
Kirk W Johnson, Kazuko Matsuda & Yuichi Iwaki
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ibudilast for the treatment of drug addiction and other neurological conditions
Kirk W Johnson, Kazuko Matsuda & Yuichi Iwaki
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ibudilast for the treatment of drug addiction and other neurological conditions
Kirk W Johnson, Kazuko Matsuda & Yuichi Iwaki
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ibudilast for the treatment of drug addiction and other neurological conditions
Kirk W Johnson, Kazuko Matsuda & Yuichi Iwaki
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ibudilast for the treatment of drug addiction and other neurological conditions
Kirk W Johnson, Kazuko Matsuda & Yuichi Iwaki
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ibudilast for the treatment of drug addiction and other neurological conditions
Kirk W Johnson, Kazuko Matsuda & Yuichi Iwaki
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ibudilast for the treatment of drug addiction and other neurological conditions
Kirk W Johnson, Kazuko Matsuda & Yuichi Iwaki
Review: Clinical Trail Outcomes: Clinical Investigation
-
Trial discontinuation: lessons for future trial design?
Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude
Clinical Trail Methodology: Clinical Investigation
-
Trial discontinuation: lessons for future trial design?
Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude
Clinical Trail Methodology: Clinical Investigation
-
Trial discontinuation: lessons for future trial design?
Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude
Clinical Trail Methodology: Clinical Investigation
-
Trial discontinuation: lessons for future trial design?
Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude
Clinical Trail Methodology: Clinical Investigation
-
Trial discontinuation: lessons for future trial design?
Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude
Clinical Trail Methodology: Clinical Investigation
-
Trial discontinuation: lessons for future trial design?
Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude
Clinical Trail Methodology: Clinical Investigation
-
Trial discontinuation: lessons for future trial design?
Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude
Clinical Trail Methodology: Clinical Investigation
-
Trial discontinuation: lessons for future trial design?
Veerle JAA Nuij, Colin J de Haar & C Janneke van der Woude
Clinical Trail Methodology: Clinical Investigation
-
A therapeutic renaissance: emergence of novel targeted agents for metastatic melanoma
C Lance Cowey
Review: Clinical Trail Outcomes: Clinical Investigation
-
A therapeutic renaissance: emergence of novel targeted agents for metastatic melanoma
C Lance Cowey
Review: Clinical Trail Outcomes: Clinical Investigation
-
A therapeutic renaissance: emergence of novel targeted agents for metastatic melanoma
C Lance Cowey
Review: Clinical Trail Outcomes: Clinical Investigation
-
A therapeutic renaissance: emergence of novel targeted agents for metastatic melanoma
C Lance Cowey
Review: Clinical Trail Outcomes: Clinical Investigation
-
A therapeutic renaissance: emergence of novel targeted agents for metastatic melanoma
C Lance Cowey
Review: Clinical Trail Outcomes: Clinical Investigation
-
A therapeutic renaissance: emergence of novel targeted agents for metastatic melanoma
C Lance Cowey
Review: Clinical Trail Outcomes: Clinical Investigation
-
A therapeutic renaissance: emergence of novel targeted agents for metastatic melanoma
C Lance Cowey
Review: Clinical Trail Outcomes: Clinical Investigation
-
A therapeutic renaissance: emergence of novel targeted agents for metastatic melanoma
C Lance Cowey
Review: Clinical Trail Outcomes: Clinical Investigation